Buscador de publicacions

Publicacions

  • Coll T, Rodrïguez-Calvo R, Barroso E, Serrano L, Eyre E, Palomer FX and Vazquez M.

    Peroxisome proliferator-activated receptor (PPAR) beta/delta: a new potential therapeutic target for the treatment of metabolic syndrome.

    Current Molecular Pharmacology . 2(1): 46-55.

  • Rodríguez-Calvo R, Serrano L, Coll T, Moullan N, Sánchez RM, Merlos M, Palomer FX, Laguna JC, Michalik L, Wahli W and Vazquez M.

    Activation of peroxisome proliferator-activated receptor beta/delta inhibits lipopolysaccharide-induced cytokine production in adipocytes by lowering nuclear factor-kappaB activity via extracellular signal-related kinase 1/2.

    Diabetes . 57(8): 2149-2157. Nº de cites: 103

    [doi:10.2337/db08-0176]

  • Coll T, Eyre E, Rodríguez-Calvo R, Palomer FX, Sánchez RM, Merlos M, Laguna JC and Vazquez M.

    Oleate reverses palmitate-induced insulin resistance and inflammation in skeletal muscle cells.

    JOURNAL OF BIOLOGICAL CHEMISTRY . 283(17): 11107-11116. Nº de cites: 284

    [doi:10.1074/jbc.M708700200]

  • Planavila A, Rodríguez-Calvo R, Palomer FX, Coll T, Sánchez RM, Merlos M, Laguna JC and Vazquez M.

    Atorvastatin inhibits GSK-3beta phosphorylation by cardiac hypertrophic stimuli.

    BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS . 1781(1-2): 26-35. Nº de cites: 15

    [doi:10.1016/j.bbalip.2007.10.009]

  • Rodríguez-Calvo R, Serrano L, Barroso E, Coll T, Palomer FX, Camins A, Sánchez RM, Alegret M, Merlos M, Pallàs M, Laguna JC and Vazquez M.

    Peroxisome proliferator-activated receptor alpha down-regulation is associated with enhanced ceramide levels in age-associated cardiac hypertrophy.

    JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES . 62(12): 1326-1336. Nº de cites: 22

    [doi:10.1093/gerona/62.12.1326]

  • Coll T, Jové M, Rodríguez-Calvo R, Eyre E, Palomer FX, Sánchez RM, Merlos M, Laguna JC and Vazquez M.

    Palmitate-mediated downregulation of peroxisome proliferator-activated receptor-gamma coactivator 1alpha in skeletal muscle cells involves MEK1/2 and nuclear factor-kappaB activation.

    Diabetes . 55(10): 2779-2787. Nº de cites: 125

    [doi:10.2337/db05-1494]